Critical Outcome Technologies (COTI) has signed a drug discovery deal with an undisclosed pharmaceutical company to use its CHEMSAS drug discovery system for the identification of small molecules. COTI will look after the discovery, ...
Tags: COTI, new drug research, CHEMSAS
Critical Outcome Technologies has received a patent for its advanced oncology drug candidate, from the US Patent and Trademark Office. The patent covers the synergistic effects of combination therapies containing COTI-2 and members of ...
Tags: oncology drug, COTI-2, anti cancer agents